{"id":"W2470583568","doi":"10.1093/annonc/mdw265","title":"Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Flatiron Health; Helsinn; Genentech; Celgene; Amgen; Pfizer; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Nivolumab; Quality of life (healthcare); Phases of clinical research; Internal medicine; Oncology; Cancer; Nursing; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001050267,0.0005591974,0.00110733,0.0001531527,0.0002229531,0.0006527369,0.0004504637,0.0005507339,0.0007618407],"category_scores_gemma":[0.001172836,0.0002007869,0.001865406,0.0002241273,0.0002995649,0.0004547009,0.0002610676,0.00127629,0.0001667407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005711028,"about_ca_system_score_gemma":0.0003777036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001695325,"about_ca_topic_score_gemma":0.003988037,"domain_scores_codex":[0.9996569,0.0001842585,0.00002031488,0.00005609031,0.00003969071,0.00004276928],"domain_scores_gemma":[0.999398,0.0002038136,0.0001774562,0.00005078864,0.00004318803,0.0001265949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5464597,0.01074115,0.26133,0.00157899,0.01416617,0.0001747887,0.000225436,0.003803645,0.01233942,0.0001932485,0.004300169,0.1446873],"study_design_scores_gemma":[0.1184321,0.102854,0.760479,0.0001813665,0.008644195,0.0002698476,0.0002182886,0.003213204,0.002172685,0.0003459634,0.003097947,0.00009145906],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961951,0.002644401,0.00004591935,0.0001338245,0.00004027403,0.00004838841,0.0004640634,0.00001008312,0.0004180111],"genre_scores_gemma":[0.9976029,0.0008625458,0.0001534532,0.000245426,0.00004407323,0.00005505504,0.0007172659,0.000005089241,0.0003141967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001695325,"threshold_uncertainty_score":0.005554378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05874758653918304,"score_gpt":0.4089947964497547,"score_spread":0.3502472099105717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}